Cardiology
MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator
1.
Zhao T, Li J, Chen AF.
Am J Physiol Endocrinol Metab. 2010 Jul;299(1):E110-6.
Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro
and in vivo.
Kane NM, Meloni M, Spencer HL, Craig MA, Strehl R, Milligan G, Houslay MD, Mountford JC, Emanueli C, Baker AH.
Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1389-97.
Plasma microRNA 499 as a biomarker of acute myocardial infarction.
Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, Goto Y, Nonogi H, Iwai N.
Clin Chem. 2010 Jul;56(7):1183-5.
An antagonism between the AKT and beta-adrenergic signaling pathways mediated through their reciprocal effects on miR-199a-5p.
Rane S, He M, Sayed D, Yan L, Vatner D, Abdellatif M.
Cell Signal. 2010 Jul;22(7):1054-62.
MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis.
Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Näär AM.
Science. 2010 Jun 18;328(5985):1566-9.
MiR-33 contributes to the regulation of cholesterol homeostasis.
Rayner KJ, Suárez Y, Dávalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernández-Hernando C.
Science. 2010 Jun 18;328(5985):1570-3.
Medicine. HDL miR-ed down by SREBP introns.
Brown MS, Ye J, Goldstein JL.
Science. 2010 Jun 18;328(5985):1495-6.
MicroRNA profiling in early hypertrophic growth of the left ventricle in rats.
Busk PK, Cirera S.
Biochem Biophys Res Commun. 2010 Jun 11;396(4):989-93.
MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism.
Lu H, Buchan RJ, Cook SA.
Cardiovasc Res. 2010 Jun 1;86(3):410-20.
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure.
Poller W, Hajjar R, Schultheiss HP, Fechner H.
Cardiovasc Res. 2010 Jun 1;86(3):353-64.
MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function.
Albinsson S, Suarez Y, Skoura A, Offermanns S, Miano JM, Sessa WC.
Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1118-26.
The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis.
Deacon DC, Nevis KR, Cashman TJ, Zhou Y, Zhao L, Washko D, Guner-Ataman B, Burns CG, Burns CE.
Development. 2010 Jun;137(11):1887-96.
MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p.
Kumarswamy R, Thum T, Anker SD.
Circ Res. 2010 May 14;106(9):e8
NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression.
Li Q, Lin X, Yang X, Chang J.
Am J Physiol Heart Circ Physiol. 2010 May;298(5):H1340-7.
MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis.
Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty KE, Lawson ND.
Nature. 2010 Apr 22;464(7292):1196-200.
MicroRNA regulatory networks in cardiovascular development.
Liu N, Olson EN.
Dev Cell. 2010 Apr 20;18(4):510-25.
miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy.
Wang K, Long B, Zhou J, Li PF.
J Biol Chem. 2010 Apr 16;285(16):11903-12.
The peripheral blood mononuclear cell microRNA signature of coronary artery disease.
Hoekstra M, van der Lans CA, Halvorsen B, Gullestad L, Kuiper J, Aukrust P, van Berkel TJ, Biessen EA.
Biochem Biophys Res Commun. 2010 Apr 9;394(3):792-7.
MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro.
Quintavalle M, Elia L, Condorelli G, Courtneidge SA.
J Cell Biol. 2010 Apr 5;189(1):13-22.
MiR423-5p as a circulating biomarker for heart failure.
Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE, Pinto YM.
Circ Res. 2010 Apr 2;106(6):1035-9.
MicroRNAs and heart failure diagnosis: MiR-acle or MiR-age?
Markham DW, Hill JA.
Circ Res. 2010 Apr 2;106(6):1011-3.
MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development.
Kalsotra A, Wang K, Li PF, Cooper TA.
Genes Dev. 2010 Apr 1;24(7):653-8.
MicroRNAs in atherosclerosis and lipoprotein metabolism.
Vickers KC, Remaley AT.
Curr Opin Endocrinol Diabetes Obes. 2010 Apr;17(2):150-5.
MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells.
Sluijter JP, van Mil A, van Vliet P, Metz CH, Liu J, Doevendans PA, Goumans MJ.
Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):859-68.
PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA.
Lin RC, Weeks KL, Gao XM, Williams RB, Bernardo BC, Kiriazis H, Matthews VB, Woodcock EA, Bouwman RD, Mollica JP, Speirs HJ,
Dawes IW, Daly RJ, Shioi T, Izumo S, Febbraio MA, Du XJ, McMullen JR.
Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):724-32.
A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial
infarcted nonhuman primates.
Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B, Bellamy V, Rücker-Martin C, Barbry P, Bel A, Bruneval P, Cowan C, Pouly J,
Mitalipov S, Gouadon E, Binder P, Hagège A, Desnos M, Renaud JF, Menasché P, Pucéat M.
J Clin Invest. 2010 Apr;120(4):1125-39.
Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac
hypertrophy.
Dong DL, Chen C, Huo R, Wang N, Li Z, Tu YJ, Hu JT, Chu X, Huang W, Yang BF.
Hypertension. 2010 Apr;55(4):946-52.
Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes.
Liu Y, Taylor NE, Lu L, Usa K, Cowley AW Jr, Ferreri NR, Yeo NC, Liang M.
Hypertension. 2010 Apr;55(4):974-82.
MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity.
Weber M, Baker MB, Moore JP, Searles CD.
Biochem Biophys Res Commun. 2010 Mar 19;393(4):643-8.
MicroRNAs add a new dimension to cardiovascular disease.
Small EM, Frost RJ, Olson EN.
Circulation. 2010 Mar 2;121(8):1022-32.
Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.
Fijalkowska I, Xu W, Comhair SA, Janocha AJ, Mavrakis LA, Krishnamachary B, Zhen L, Mao T, Richter A, Erzurum SC, Tuder RM.
Am J Pathol. 2010 Mar;176(3):1130-8.
MicroRNAs in angiogenesis and vascular smooth muscle cell function.
Daubman S.
Circ Res. 2010 Feb 19;106(3):423-5.
MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells.
Qin X, Wang X, Wang Y, Tang Z, Cui Q, Xi J, Li YS, Chien S, Wang N.
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3240-4.
Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth.
Wang KC, Garmire LX, Young A, Nguyen P, Trinh A, Subramaniam S, Wang N, Shyy JY, Li YS, Chien S.
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3234-9.
The year in heart failure.
Tang WH, Francis GS.
J Am Coll Cardiol. 2010 Feb 16;55(7):688-96.
MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes.
Nishi H, Ono K, Iwanaga Y, Horie T, Nagao K, Takemura G, Kinoshita M, Kuwabara Y, Mori RT, Hasegawa K, Kita T, Kimura T.
J Biol Chem. 2010 Feb 12;285(7):4920-30.
Roles for endoplasmic reticulum-associated degradation and the novel endoplasmic reticulum stress response gene Derlin-3 in the
ischemic heart.
Belmont PJ, Chen WJ, San Pedro MN, Thuerauf DJ, Gellings Lowe N, Gude N, Hilton B, Wolkowicz R, Sussman MA, Glembotski CC.
Circ Res. 2010 Feb 5;106(2):307-16.
The year's successes in failure: Circulation Research takes a look at the key research developments of 2009 that are providing hope in the
field of heart failure.
Williams R.
Circ Res. 2010 Feb 5;106(2):213-5.
Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression.
Chan MC, Hilyard AC, Wu C, Davis BN, Hill NS, Lal A, Lieberman J, Lagna G, Hata A.
EMBO J. 2010 Feb 3;29(3):559-73.
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-
overloaded adult hearts.
Matkovich SJ, Wang W, Tu Y, Eschenbacher WH, Dorn LE, Condorelli G, Diwan A, Nerbonne JM, Dorn GW 2nd.
Circ Res. 2010 Jan 8;106(1):166-75.
Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells.
Lee TH, Song SH, Kim KL, Yi JY, Shin GH, Kim JY, Kim J, Han YM, Lee SH, Lee SH, Shim SH, Suh W.
Circ Res. 2010 Jan 8;106(1):120-8.
Career moves: induced pluripotent cells from human aortic smooth muscle cells can efficiently redifferentiate into parental phenotype.
Kishore R, Krishnamurthy P, Losordo DW.
Circ Res. 2010 Jan 8;106(1):7-9.
The role of microRNA-133 in cardiac hypertrophy uncovered.
Abdellatif M.
Circ Res. 2010 Jan 8;106(1):16-8.
miRNA-processing enzyme Dicer is necessary for cardiac outflow tract alignment and chamber septation.
Saxena A, Tabin CJ.
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):87-91.
Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction.
Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, Li K, Yu B, Li Z, Wang R, Wang L, Li Q, Wang N, Shan H, Li Z, Yang B.
Biochem Biophys Res Commun. 2010 Jan 1;391(1):73-7.
MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.
Pan ZW, Lu YJ, Yang BF.
Acta Pharmacol Sin. 2010 Jan;31(1):1-9.
The genetics of cardiovascular disease: new insights from emerging approaches.
Chico TJ, Milo M, Crossman DC.
J Pathol. 2010 Jan;220(2):186-97.
miR133a regulates cardiomyocyte hypertrophy in diabetes.
Feng B, Chen S, George B, Feng Q, Chakrabarti S.
Diabetes Metab Res Rev. 2010 Jan;26(1):40-9.
The roles of microRNAs in heart diseases: a novel important regulator.
Cai B, Pan Z, Lu Y.
Curr Med Chem. 2010;17(5):407-11.
Pathway analysis of microRNAs in mouse heart development.
Liu G, Ding M, Wang H, Huang J, Jing Q, Shen B.
Int J Bioinform Res Appl. 2010;6(1):12-20.
Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection.
Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Köppel T, Jahantigh MN, Lutgens E, Wang S, Olson
EN, Schober A, Weber C.
Sci Signal. 2009 Dec 8;2(100):ra81.
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in
physiological and pathological conditions.
Elia L, Contu R, Quintavalle M, Varrone F, Chimenti C, Russo MA, Cimino V, De Marinis L, Frustaci A, Catalucci D, Condorelli G.
Circulation. 2009 Dec 8;120(23):2377-85.
MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection.
Lu Y, Zhang Y, Shan H, Pan Z, Li X, Li B, Xu C, Zhang B, Zhang F, Dong D, Song W, Qiao G, Yang B.
Cardiovasc Res. 2009 Dec 1;84(3):434-41.
Knockdown of microRNA-181 by lentivirus mediated siRNA expression vector decreases the arrhythmogenic effect of skeletal myoblast
transplantation in rat with myocardial infarction.
Li YG, Zhang PP, Jiao KL, Zou YZ.
Microvasc Res. 2009 Dec;78(3):393-404.
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human
disease.
Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J, Courtneidge SA, Condorelli
G.
Cell Death Differ. 2009 Dec;16(12):1590-8.
MicroRNAs and beyond: the heart reveals its treasures.
Schroen B, Heymans S.
Hypertension. 2009 Dec;54(6):1189-94.
MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes.
Horie T, Ono K, Nishi H, Iwanaga Y, Nagao K, Kinoshita M, Kuwabara Y, Takanabe R, Hasegawa K, Kita T, Kimura T.
Biochem Biophys Res Commun. 2009 Nov 13;389(2):315-20.
Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis.
Chan LS, Yue PY, Mak NK, Wong RN.
Eur J Pharm Sci. 2009 Nov 5;38(4):370-7.
MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease.
Zhang C.
Cell Cycle. 2009 Nov 1;8(21):3469-73.
Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1.
Shan H, Li X, Pan Z, Zhang L, Cai B, Zhang Y, Xu C, Chu W, Qiao G, Li B, Lu Y, Yang B.
Br J Pharmacol. 2009 Nov;158(5):1227-35.
Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading.
Divakaran V, Adrogue J, Ishiyama M, Entman ML, Haudek S, Sivasubramanian N, Mann DL.
Circ Heart Fail. 2009 Nov;2(6):633-42.
A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.
van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ Jr, Olson EN.
Dev Cell. 2009 Nov;17(5):662-73.
MicroRNAs as novel myocardial biomarkers.
Margulies KB.
Clin Chem. 2009 Nov;55(11):1897-9.
Plasma miR-208 as a biomarker of myocardial injury.
Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N.
Clin Chem. 2009 Nov;55(11):1944-9.
Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury.
Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, Johnson JM, Sina JF, Fare TL, Sistare FD, Glaab WE.
Clin Chem. 2009 Nov;55(11):1977-83.
MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction.
Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X, Wang D, Krall TJ, Delphin ES, Zhang C.
J Biol Chem. 2009 Oct 23;284(43):29514-25.
MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1.
Menghini R, Casagrande V, Cardellini M, Martelli E, Terrinoni A, Amati F, Vasa-Nicotera M, Ippoliti A, Novelli G, Melino G, Lauro R,
Federici M.
Circulation. 2009 Oct 13;120(15):1524-32.
Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks.
Naga Prasad SV, Duan ZH, Gupta MK, Surampudi VS, Volinia S, Calin GA, Liu CG, Kotwal A, Moravec CS, Starling RC, Perez DM, Sen
S, Wu Q, Plow EF, Croce CM, Karnik S.
J Biol Chem. 2009 Oct 2;284(40):27487-99.
MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2.
Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, Loscalzo J.
Cell Metab. 2009 Oct;10(4):273-84.
MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury.
Xin M, Small EM, Sutherland LB, Qi X, McAnally J, Plato CF, Richardson JA, Bassel-Duby R, Olson EN.
Genes Dev. 2009 Sep 15;23(18):2166-78.
Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure.
Rao PK, Toyama Y, Chiang HR, Gupta S, Bauer M, Medvid R, Reinhardt F, Liao R, Krieger M, Jaenisch R, Lodish HF, Blelloch R.
Circ Res. 2009 Sep 11;105(6):585-94.
Role of specific microRNAs for endothelial function and angiogenesis.
Wu F, Yang Z, Li G.
Biochem Biophys Res Commun. 2009 Sep 4;386(4):549-53.
Non-cell-autonomous effects of vector-expressed regulatory RNAs in mammalian heart cells.
Kizana E, Cingolani E, Marbán E.
Gene Ther. 2009 Sep;16(9):1163-8.
Heart development before beating.
Nakajima Y, Sakabe M, Matsui H, Sakata H, Yanagawa N, Yamagishi T.
Anat Sci Int. 2009 Sep;84(3):67-76.
MicroRNA-modulated targeting of vascular smooth muscle cells.
Parmacek MS.
J Clin Invest. 2009 Sep;119(9):2526-8.
Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster.
Boettger T, Beetz N, Kostin S, Schneider J, Krüger M, Hein L, Braun T.
J Clin Invest. 2009 Sep;119(9):2634-47.
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.
Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, Willis MS, Selzman CH, Wang
DZ.
J Clin Invest. 2009 Sep;119(9):2772-86.
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity.
Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D.
Nature. 2009 Aug 6;460(7256):705-10.
Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines.
Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai B, Wang N, Li X, Feng T, Hong Y, Yang B.
Cardiovasc Res. 2009 Aug 1;83(3):465-72.
MicroRNAs in cardiovascular biology and heart disease.
Catalucci D, Gallo P, Condorelli G.
Circ Cardiovasc Genet. 2009 Aug;2(4):402-8.
Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis.
van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-Rietdijk AM, Baelde HJ, Monge M, Vos JB, de Boer HC, Quax
PH, Rabelink TJ, van Zonneveld AJ.
J Cell Mol Med. 2009 Aug;13(8A):1577-85.
MicroRNA is a new diagnostic and therapeutic target for cardiovascular disease and regenerative medicine.
Kaneda R, Fukuda K.
Circ J. 2009 Aug;73(8):1397-8.
Basic and translational research: from molecule, to mouse, to man.
Adams V, Möbius-Winkler S, Schuler G.
Eur J Cardiovasc Prev Rehabil. 2009 Aug;16 Suppl 2:S48-52.
miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy.
Lin Z, Murtaza I, Wang K, Jiao J, Gao J, Li PF.
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12103-8.
MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES, Zhang C.
Circ Res. 2009 Jul 17;105(2):158-66.
Translational control of FOG-2 expression in cardiomyocytes by microRNA-130a.
Kim GH, Samant SA, Earley JU, Svensson EC.
PLoS One. 2009 Jul 7;4(7):e6161.
MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated
monocyte/macrophages.
Chen T, Huang Z, Wang L, Wang Y, Wu F, Meng S, Wang C.
Cardiovasc Res. 2009 Jul 1;83(1):131-9.
Redox signalling and miRNA function in cardiomyocytes.
Brewer AC, Shah AM.
J Mol Cell Cardiol. 2009 Jul;47(1):2-4.
MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4.
Cheng Y, Liu X, Zhang S, Lin Y, Yang J, Zhang C.
J Mol Cell Cardiol. 2009 Jul;47(1):5-14.
MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.
Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M,
Tjwa M, Urbich C, Zeiher AM, Dimmeler S.
Science. 2009 Jun 26;324(5935):1710-3.
DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy.
Kuhn C, Frank D, Will R, Jaschinski C, Frauen R, Katus HA, Frey N.
J Biol Chem. 2009 Jun 19;284(25):17320-7.
[Mechanotransduction in cardiovascular and skeletal muscle]
Miyasaka K, Kida Y, Ogura T.
Seikagaku. 2009 Jun;81(6):494-501.
MicroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic
targets.
Silvestri P, Di Russo C, Rigattieri S, Fedele S, Todaro D, Ferraiuolo G, Altamura G, Loschiavo P.
Recent Pat Cardiovasc Drug Discov. 2009 Jun;4(2):109-18.
Role of microRNAs in cardiac hypertrophy and heart failure.
Wang N, Zhou Z, Liao X, Zhang T.
IUBMB Life. 2009 Jun;61(6):566-71.
MicroRNA control of muscle development and disease.
Williams AH, Liu N, van Rooij E, Olson EN.
Curr Opin Cell Biol. 2009 Jun;21(3):461-9.
MicroRNAs and cardiac pathology.
Latronico MV, Condorelli G.
Nat Rev Cardiol. 2009 Jun;6(6):419-29.
[Experimental analysis of microRNAs related to cardiac development differential expression]
Shi XX, Lai DD, Zhang JY, Chu MP, Wang SB, Ni QM, Huang XY, Zhang HQ, Yang DY.
Zhonghua Yi Xue Za Zhi. 2009 May 26;89(20):1416-20.
Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92
pathway.
Brock M, Trenkmann M, Gay RE, Michel BA, Gay S, Fischler M, Ulrich S, Speich R, Huber LC.
Circ Res. 2009 May 22;104(10):1184-91.
MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20.
Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K, Nicolaou P, Pritchard TJ, Fan GC.
Circulation. 2009 May 5;119(17):2357-66.
Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease.
Minami Y, Satoh M, Maesawa C, Takahashi Y, Tabuchi T, Itoh T, Nakamura M.
Eur J Clin Invest. 2009 May;39(5):359-67.
MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2.
Tang Y, Zheng J, Sun Y, Wu Z, Liu Z, Huang G.
Int Heart J. 2009 May;50(3):377-87.
MicroRNAs: regulating a change of heart.
Barringhaus KG, Zamore PD.
Circulation. 2009 Apr 28;119(16):2217-24.
Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction.
Shan ZX, Lin QX, Fu YH, Deng CY, Zhou ZL, Zhu JN, Liu XY, Zhang YY, Li Y, Lin SG, Yu XY.
Biochem Biophys Res Commun. 2009 Apr 17;381(4):597-601.
Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in
cardiac myocytes.
Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J, Vatner DE, Vatner SF, Abdellatif M.
Circ Res. 2009 Apr 10;104(7):879-86.
MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and
tensin homologue.
Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ, Sen CK.
Cardiovasc Res. 2009 Apr 1;82(1):21-9.
MiRNA-21: a key to controlling the cardiac fibroblast compartment?
Haghikia A, Hilfiker-Kleiner D.
Cardiovasc Res. 2009 Apr 1;82(1):1-3.
Extracardiac approaches to protecting the heart.
Valen G.
Eur J Cardiothorac Surg. 2009 Apr;35(4):651-7.
MicroRNAs as a therapeutic target for cardiovascular diseases.
Mishra PK, Tyagi N, Kumar M, Tyagi SC.
J Cell Mol Med. 2009 Apr;13(4):778-89.
MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes.
Ikeda S, He A, Kong SW, Lu J, Bejar R, Bodyak N, Lee KH, Ma Q, Kang PM, Golub TR, Pu WT.
Mol Cell Biol. 2009 Apr;29(8):2193-204.
MicroRNA-221 regulates high glucose-induced endothelial dysfunction.
Li Y, Song YH, Li F, Yang T, Lu YW, Geng YJ.
Biochem Biophys Res Commun. 2009 Mar 27;381(1):81-3.
MicroRNA regulation of cardiovascular development.
Cordes KR, Srivastava D.
Circ Res. 2009 Mar 27;104(6):724-32.
Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells.
Lin Y, Liu X, Cheng Y, Yang J, Huo Y, Zhang C.
J Biol Chem. 2009 Mar 20;284(12):7903-13.
A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70.
Yin C, Salloum FN, Kukreja RC.
Circ Res. 2009 Mar 13;104(5):572-5.
Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by
biomechanical support.
Matkovich SJ, Van Booven DJ, Youker KA, Torre-Amione G, Diwan A, Eschenbacher WH, Dorn LE, Watson MA, Margulies KB, Dorn GW
2nd.
Circulation. 2009 Mar 10;119(9):1263-71.
Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological
hypertrophy.
Suckau L, Fechner H, Chemaly E, Krohn S, Hadri L, Kockskämper J, Westermann D, Bisping E, Ly H, Wang X, Kawase Y, Chen J, Liang
L, Sipo I, Vetter R, Weger S, Kurreck J, Erdmann V, Tschope C, Pieske B, Lebeche D, Schultheiss HP, Hajjar RJ, Poller WC.
Circulation. 2009 Mar 10;119(9):1241-52.
miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha
and causing CaMKII-dependent hyperphosphorylation of RyR2.
Terentyev D, Belevych AE, Terentyeva R, Martin MM, Malana GE, Kuhn DE, Abdellatif M, Feldman DS, Elton TS, Györke S.
Circ Res. 2009 Feb 27;104(4):514-21.
A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia.
Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C.
Circ Res. 2009 Feb 27;104(4):476-87.
Ca(2+) signaling domains responsible for cardiac hypertrophy and arrhythmias.
Houser SR.
Circ Res. 2009 Feb 27;104(4):413-5.
MicroRNAs as novel regulators of angiogenesis.
Suárez Y, Sessa WC.
Circ Res. 2009 Feb 27;104(4):442-54.
[Prediction of the microRNAs related to cardiovascular diseases by bioinformatics]
Zhang F, Lu M, Zhang QP, Zhang FC, Gao W, Cui QH.
Beijing Da Xue Xue Bao. 2009 Feb 18;41(1):112-6.
Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype.
Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A.
J Biol Chem. 2009 Feb 6;284(6):3728-38.
MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2
diabetic rats.
Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM.
Clin Exp Pharmacol Physiol. 2009 Feb;36(2):181-8.
RNA silencing: small RNA-mediated posttranscriptional regulation of mRNA and the implications for heart electropathophysiology.
Latronico MV, Condorelli G.
J Cardiovasc Electrophysiol. 2009 Feb;20(2):230-7.
Do microRNAs regulate myocardial fibrosis?
Díez J.
Nat Clin Pract Cardiovasc Med. 2009 Feb;6(2):88-9.
miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.
Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P,
Maessen JG, Heymans S, Pinto YM, Creemers EE.
Circ Res. 2009 Jan 30;104(2):170-8
Searching for miR-acles in cardiac fibrosis.
van Rooij E, Olson EN.
Circ Res. 2009 Jan 30;104(2):138-40.
MicroRNAs: opening a new vein in angiogenesis research.
Fish JE, Srivastava D.
Sci Signal. 2009 Jan 6;2(52):pe1.
Insights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targets.
Zorio E, Medina P, Rueda J, Millán JM, Arnau MA, Beneyto M, Marín F, Gimeno JR, Osca J, Salvador A, España F, Estellés A.
Cardiovasc Hematol Agents Med Chem. 2009 Jan;7(1):82-90.
Genetic markers for coronary artery disease.
Baudhuin LM.
Clin Lab Sci. 2009 Fall;22(4):226-32.
[Effects of RNA on blood circulation and its adrenergic and cholinergic regulation]
Neshcheret OP, Tkachuk ZIu, Moĭbenko OO.
Fiziol Zh. 2009;55(6):20-9.
MicroRNA microarray expression profiling in human myocardial infarction.
Bostjancic E, Zidar N, Glavac D.
Dis Markers. 2009;27(6):255-68.
MicroRNAs are involved in homocysteine-induced cardiac remodeling.
Mishra PK, Tyagi N, Kundu S, Tyagi SC.
Cell Biochem Biophys. 2009;55(3):153-62.
Micromanaging vascular biology: tiny microRNAs play big band.
Sen CK, Gordillo GM, Khanna S, Roy S.
J Vasc Res. 2009;46(6):527-40.
MicroRNA: novel regulators involved in the remodeling and reverse remodeling of the heart.
Wang J, Xu R, Lin F, Zhang S, Zhang G, Hu S, Zheng Z.
Cardiology. 2009;113(2):81-8.
Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice.
Yin C, Wang X, Kukreja RC.
FEBS Lett. 2008 Dec 24;582(30):4137-42.
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.
Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J,
Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J,
Engelhardt S.
Nature. 2008 Dec 18;456(7224):980-4.
microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart.
Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R, Olson EN.
Genes Dev. 2008 Dec 1;22(23):3242-54.
Right into the heart of microRNA-133a.
Meder B, Katus HA, Rottbauer W.
Genes Dev. 2008 Dec 1;22(23):3227-31.
Changes in regulatory microRNA expression in myocardium of heart failure patients on left ventricular assist device support.
Schipper ME, van Kuik J, de Jonge N, Dullens HF, de Weger RA.
J Heart Lung Transplant. 2008 Dec;27(12):1282-5.
Expression, activity, and pro-hypertrophic effects of PDE5A in cardiac myocytes.
Zhang M, Koitabashi N, Nagayama T, Rambaran R, Feng N, Takimoto E, Koenke T, O'Rourke B, Champion HC, Crow MT, Kass DA.
Cell Signal. 2008 Dec;20(12):2231-6.
Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis.
Asada S, Takahashi T, Isodono K, Adachi A, Imoto H, Ogata T, Ueyama T, Matsubara H, Oh H.
Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2512-21.
Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1.
Yu XY, Song YH, Geng YJ, Lin QX, Shan ZX, Lin SG, Li Y.
Biochem Biophys Res Commun. 2008 Nov 21;376(3):548-52.
Serum response factor orchestrates nascent sarcomerogenesis and silences the biomineralization gene program in the heart.
Niu Z, Iyer D, Conway SJ, Martin JF, Ivey K, Srivastava D, Nordheim A, Schwartz RJ.
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17824-9.
microRNA-138 modulates cardiac patterning during embryonic development.
Morton SU, Scherz PJ, Cordes KR, Ivey KN, Stainier DY, Srivastava D.
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17830-5.
The emerging role of microRNAs in cardiac remodeling and heart failure.
Divakaran V, Mann DL.
Circ Res. 2008 Nov 7;103(10):1072-83.
Toward microRNA-based therapeutics for heart disease: the sense in antisense.
van Rooij E, Marshall WS, Olson EN.
Circ Res. 2008 Oct 24;103(9):919-28.
Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis.
Suárez Y, Fernández-Hernando C, Yu J, Gerber SA, Harrison KD, Pober JS, Iruela-Arispe ML, Merkenschlager M, Sessa WC.
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14082-7.
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis.
van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN.
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13027-32.
Feedback remodeling of cardiac potassium current expression: a novel potential mechanism for control of repolarization reserve.
Xiao L, Xiao J, Luo X, Lin H, Wang Z, Nattel S.
Circulation. 2008 Sep 2;118(10):983-92.
Repolarization reserve: a moving target.
Roden DM.
Circulation. 2008 Sep 2;118(10):981-2.
MicroRNAs: novel regulators in cardiac development and disease.
Thum T, Catalucci D, Bauersachs J.
Cardiovasc Res. 2008 Sep 1;79(4):562-70.
Role of microRNAs in vascular diseases, inflammation, and angiogenesis.
Urbich C, Kuehbacher A, Dimmeler S.
Cardiovasc Res. 2008 Sep 1;79(4):581-8.
MicroRNAs: components of an integrated system controlling cardiac development, physiology, and disease pathogenesis.
Condorelli G, Dimmeler S.
Cardiovasc Res. 2008 Sep 1;79(4):551-2.
Control of cardiac excitability by microRNAs.
Yang B, Lu Y, Wang Z.
Cardiovasc Res. 2008 Sep 1;79(4):571-80.
[What's new in the couple thyroid and heart in 2008?]
François M, Delemer B.
Ann Endocrinol (Paris). 2008 Sep;69 Suppl 1:S37-43.
MicroRNA and cardiac pathologies.
Latronico MV, Catalucci D, Condorelli G.
Physiol Genomics. 2008 Aug 15;34(3):239-42.
MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths.
Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H, Yan L, Malhotra A, Vatner D, Abdellatif M.
Mol Biol Cell. 2008 Aug;19(8):3272-82.
miRNA expression in the failing human heart: functional correlates.
Sucharov C, Bristow MR, Port JD.
J Mol Cell Cardiol. 2008 Aug;45(2):185-92.
On the road to the definition of the cardiac miRNome in human disease states.
Latronico MV, Condorelli G.
J Mol Cell Cardiol. 2008 Aug;45(2):162-4.
The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis.
Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN.
Dev Cell. 2008 Aug;15(2):261-71.
miR-126 regulates angiogenic signaling and vascular integrity.
Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D.
Dev Cell. 2008 Aug;15(2):272-84.
p100 increases AT1R expression through interaction with AT1R 3'-UTR.
Paukku K, Kalkkinen N, Silvennoinen O, Kontula KK, Lehtonen JY.
Nucleic Acids Res. 2008 Aug;36(13):4474-87.
Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart.
Luo X, Lin H, Pan Z, Xiao J, Zhang Y, Lu Y, Yang B, Wang Z.
J Biol Chem. 2008 Jul 18;283(29):20045-52.
[Perspective of microRNA in cardiovascular-associated diseases]
Zhang XB, Chen BS.
Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Jul;36(7):661-3.
miRNAs at the heart of the matter.
Wang Z, Luo X, Lu Y, Yang B.
J Mol Med. 2008 Jul;86(7):771-83.
Optimizing gene delivery vectors for the treatment of heart disease.
Gray SJ, Samulski RJ.
Expert Opin Biol Ther. 2008 Jul;8(7):911-22.
MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3.
Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC, Martelli F.
J Biol Chem. 2008 Jun 6;283(23):15878-83.
Taking microRNAs to heart.
Callis TE, Wang DZ.
Trends Mol Med. 2008 Jun;14(6):254-60.
RNA induction and inheritance of epigenetic cardiac hypertrophy in the mouse.
Wagner KD, Wagner N, Ghanbarian H, Grandjean V, Gounon P, Cuzin F, Rassoulzadegan M.
Dev Cell. 2008 Jun;14(6):962-9.
MicroRNAs: role in cardiovascular biology and disease.
Zhang C.
Clin Sci (Lond). 2008 Jun;114(12):699-706.
Does the effect of microRNAs in vascular neointimal formation depend on cell cycle phase?
Silvestri P, Rigattieri S, Loschiavo P.
Circ Res. 2008 May 9;102(9):e101; author reply e102.
MicroRNAs flex their muscles.
van Rooij E, Liu N, Olson EN.
Trends Genet. 2008 Apr;24(4):159-66.
Pharmacological approaches to regenerative strategies for the treatment of cardiovascular diseases.
Pucéat M.
Curr Opin Pharmacol. 2008 Apr;8(2):189-92.
Implication of microRNAs in the cardiovascular system.
Scalbert E, Bril A.
Curr Opin Pharmacol. 2008 Apr;8(2):181-8.
MicroRNAs control gene expression: importance for cardiac development and pathophysiology.
Catalucci D, Latronico MV, Condorelli G.
Ann N Y Acad Sci. 2008 Mar;1123:20-9.
Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells.
Shilo S, Roy S, Khanna S, Sen CK.
Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):471-7.
The developmental genetics of congenital heart disease.
Bruneau BG.
Nature. 2008 Feb 21;451(7181):943-8.
Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure.
Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z, Rojas M, Hammond SM, Schneider MD, Selzman CH, Meissner G,
Patterson C, Hannon GJ, Wang DZ.
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2111-6.
Muscling through the microRNA world.
Callis TE, Deng Z, Chen JF, Wang DZ.
Exp Biol Med (Maywood). 2008 Feb;233(2):131-8.
Inversion region for hypertension and brachydactyly on chromosome 12p features multiple splicing and noncoding RNA.
Bähring S, Kann M, Neuenfeld Y, Gong M, Chitayat D, Toka HR, Toka O, Plessis G, Maass P, Rauch A, Aydin A, Luft FC.
Hypertension. 2008 Feb;51(2):426-31.
Targeting microRNA expression to regulate angiogenesis.
Kuehbacher A, Urbich C, Dimmeler S.
Trends Pharmacol Sci. 2008 Jan;29(1):12-5.
Molecular regulation of cardiac hypertrophy.
Barry SP, Davidson SM, Townsend PA.
Int J Biochem Cell Biol. 2008;40(10):2023-39.
Heart failure: targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment.
Latronico MV, Elia L, Condorelli G, Catalucci D.
Int J Biochem Cell Biol. 2008;40(9):1643-8.
An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133.
Liu N, Williams AH, Kim Y, McAnally J, Bezprozvannaya S, Sutherland LB, Richardson JA, Bassel-Duby R, Olson EN.
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20844-9.
Emerging role of microRNAs in cardiovascular biology.
Latronico MV, Catalucci D, Condorelli G.
Circ Res. 2007 Dec 7;101(12):1225-36.
[MicroRNAs can be expressed in cardiomyocyte-like cells differentiated from human mesenchymal stem cells]
Shan ZX, Lin QX, Yu XY, Deng CY, Li XH, Zhang XC, Liu XY, Fu YH.
Nan Fang Yi Ke Da Xue Xue Bao. 2007 Dec;27(12):1813-6.
Serum response factor micromanaging cardiogenesis.
Niu Z, Li A, Zhang SX, Schwartz RJ.
Curr Opin Cell Biol. 2007 Dec;19(6):618-27.
Altered microRNA expression in human heart disease.
Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B, Pu WT.
Physiol Genomics. 2007 Nov 14;31(3):367-73.
microRNAs put their signatures on the heart.
van Rooij E, Olson EN.
Physiol Genomics. 2007 Nov 14;31(3):365-6.
MicroRNAs in the broken heart.
Bauersachs J, Thum T.
Eur J Clin Invest. 2007 Nov;37(11):829-33.
The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9
in cardiomyocytes.
Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H, Xiao J, Shan H, Wang Z, Yang B.
J Cell Sci. 2007 Sep 1;120(Pt 17):3045-52.
MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets.
van Rooij E, Olson EN.
J Clin Invest. 2007 Sep;117(9):2369-76.
Transcriptional activation by stimulating protein 1 and post-transcriptional repression by muscle-specific microRNAs of IKs-encoding
genes and potential implications in regional heterogeneity of their expressions.
Luo X, Xiao J, Lin H, Li B, Lu Y, Yang B, Wang Z.
J Cell Physiol. 2007 Aug;212(2):358-67.
MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure.
Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J, Haverich A, Gross C, Engelhardt
S, Ertl G, Bauersachs J.
Circulation. 2007 Jul 17;116(3):258-67.
Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis.
Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S.
Circ Res. 2007 Jul 6;101(1):59-68.
Resizing the genomic regulation of restenosis.
Matsumoto T, Hwang PM.
Circ Res. 2007 Jun 8;100(11):1537-9.
MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion
formation.
Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C.
Circ Res. 2007 Jun 8;100(11):1579-88.
MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?
Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C.
Am J Pathol. 2007 Jun;170(6):1831-40.
Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.
Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M, Rojas M, Hammond SM, Wang DZ.
J Mol Cell Cardiol. 2007 Jun;42(6):1137-41.
MicroRNA-133 controls cardiac hypertrophy.
Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Hoydal M,
Autore C, Russo MA, Dorn GW 2nd, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G.
Nat Med. 2007 May;13(5):613-8.
MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts.
Xiao J, Luo X, Lin H, Zhang Y, Lu Y, Wang N, Zhang Y, Yang B, Wang Z.
J Biol Chem. 2007 Apr 27;282(17):12363-7.
Control of stress-dependent cardiac growth and gene expression by a microRNA.
van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN.
Science. 2007 Apr 27;316(5824):575-9.
Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells.
Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC.
Circ Res. 2007 Apr 27;100(8):1164-73.
Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2.
Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D.
Cell. 2007 Apr 20;129(2):303-17.
miR-1-2 gets to the heart of the matter.
Mishima Y, Stahlhut C, Giraldez AJ.
Cell. 2007 Apr 20;129(2):247-9.
The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2.
Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z.
Nat Med. 2007 Apr;13(4):486-91.
MicroRNA may have macro effect on sudden death.
Anderson ME, Mohler PJ.
Nat Med. 2007 Apr;13(4):410-1.
MicroRNAs in skeletal and cardiac muscle development.
Callis TE, Chen JF, Wang DZ.
DNA Cell Biol. 2007 Apr;26(4):219-25.
MicroRNAs play an essential role in the development of cardiac hypertrophy.
Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M.
Circ Res. 2007 Feb 16;100(3):416-24.
Thoracic skeletal defects and cardiac malformations: a common epigenetic link?
Weston AD, Ozolins TR, Brown NA.
Birth Defects Res C Embryo Today. 2006 Dec;78(4):354-70.
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.
van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN.
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18255-60.
MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling.
Kwon C, Han Z, Olson EN, Srivastava D.
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):18986-91.
Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis.
Zhao Y, Samal E, Srivastava D.
Nature. 2005 Jul 14;436(7048):214-20.
Developmental biology: tiny brakes for a growing heart.
Bruneau BG.
Nature. 2005 Jul 14;436(7048):181-2.